Patrick Mousaw

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sunovion Pharmaceuticals Inc.. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Mousaw. Retrieved from https://idiyas.com/inventor/patrick-mousaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 37.5

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

8 out of 130

Sunovion Pharmaceuticals Inc.

patents

Years Active: 2012-2014

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8889686 - Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone (2014-11-18),

2. 8889685 - Method for treating a sleep disorder with eszopiclone maleate (2014-11-18),

3. 8809332 - Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone (2014-08-19),

4. 8541416 - Method for treating a sleep disorder with a dosage form of a zopiclone or eszopiclone L-malate salt (2013-09-24),

5. 8497268 - Method for providing blood levels of eszopiclone with maleate salts (2013-07-30),

6. 8497267 - Method for treating a sleep disorder with a dosage form of besylate salts of zopiclone or eszopiclone (2013-07-30),

7. 8268832 - Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine (2012-09-18),

8. 8198278 - Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine (2012-06-12),

Title: The Innovations of Patrick Mousaw

Introduction

Patrick Mousaw is an accomplished inventor based in Granger, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of sleep disorders. With a total of eight patents to his name, Mousaw's work has had a notable impact on the industry.

Latest Patents

Among his latest patents is a method for treating a sleep disorder with eszopiclone maleate. This patent involves maleate salts of a specific compound that are useful for treating sleep disorders. Another significant patent focuses on decreasing the bitterness of a pharmaceutical dosage form containing zopiclone. This innovation involves L malate salts of the same compound, aimed at improving the palatability of eszopiclone dosage forms.

Career Highlights

Throughout his career, Patrick Mousaw has worked with prominent companies in the pharmaceutical sector, including Sunovion Pharmaceuticals Inc. and Sepracor, Inc. His expertise in drug formulation and development has been instrumental in advancing treatments for various conditions.

Collaborations

Mousaw has collaborated with notable professionals in his field, including H. Scott Wilkinson and Richard Hsia. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Patrick Mousaw's contributions to pharmaceutical innovations, particularly in sleep disorder treatments, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving patient care through effective pharmaceutical solutions.

Profile summary based on public USPTO records.